HealthSouth Corp. (NYSE:HLS) CFO Douglas E. Coltharp acquired 6,450 shares of the business’s stock in a transaction dated Wednesday, November 9th. The shares were bought at an average cost of $39.14 per share, for a total transaction of $252,453.00. Following the transaction, the chief financial officer now directly owns 104,637 shares of the company’s stock, valued at approximately $4,095,492.18. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of HealthSouth Corp. (NYSE:HLS) opened at 40.72 on Wednesday. The firm has a market cap of $3.66 billion, a P/E ratio of 16.97 and a beta of 0.90. The stock’s 50 day moving average is $40.19 and its 200 day moving average is $40.45. HealthSouth Corp. has a 52 week low of $30.26 and a 52 week high of $43.38.

HealthSouth Corp. (NYSE:HLS) last released its earnings results on Thursday, October 27th. The company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.05. The company earned $926.80 million during the quarter, compared to the consensus estimate of $448.60 million. HealthSouth Corp. had a net margin of 6.31% and a return on equity of 29.27%. The company’s revenue was up 19.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.52 EPS. On average, equities research analysts predict that HealthSouth Corp. will post $2.55 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be given a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 2.36%. The ex-dividend date of this dividend is Thursday, December 29th. HealthSouth Corp.’s payout ratio is currently 40.17%.

HLS has been the topic of several recent analyst reports. Zacks Investment Research raised HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Monday, October 31st. SunTrust Banks Inc. set a $54.00 target price on HealthSouth Corp. and gave the company a “buy” rating in a report on Monday, August 1st. Wells Fargo & Co. reissued a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 11th. JMP Securities reissued a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 4th. Finally, Mizuho lowered HealthSouth Corp. from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. HealthSouth Corp. has a consensus rating of “Buy” and an average target price of $46.57.

Several large investors have recently added to or reduced their stakes in HLS. Creative Planning increased its stake in HealthSouth Corp. by 2.0% in the second quarter. Creative Planning now owns 2,858 shares of the company’s stock valued at $111,000 after buying an additional 56 shares during the last quarter. Acrospire Investment Management LLC increased its stake in HealthSouth Corp. by 32.1% in the second quarter. Acrospire Investment Management LLC now owns 3,700 shares of the company’s stock valued at $144,000 after buying an additional 900 shares during the last quarter. Sit Investment Associates Inc. increased its stake in HealthSouth Corp. by 43.0% in the third quarter. Sit Investment Associates Inc. now owns 3,575 shares of the company’s stock valued at $145,000 after buying an additional 1,075 shares during the last quarter. LSV Asset Management bought a new stake in HealthSouth Corp. during the third quarter valued at $164,000. Finally, Societe Generale bought a new stake in HealthSouth Corp. during the second quarter valued at $172,000. 96.10% of the stock is owned by institutional investors.

HealthSouth Corp. Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.

5 Day Chart for NYSE:HLS

Receive News & Stock Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related stocks with our FREE daily email newsletter.